Real-time enrollment status for this hemophilia a clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 12:27 AM UTC
| NCT Number | NCT05611801 |
| Recruiting Status | Recruiting |
| Condition | Hemophilia A |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | August 10, 2026 (3 weeks ago) |
As of August 31, 2026: Clinical trial NCT05611801 is currently recruiting participants. This phase3 study for hemophilia a is actively seeking new participants at 1 location across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05611801 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05611801 was last updated 3 weeks ago (August 10, 2026). HelloStudys verifies this status automatically.